Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Truebinding, Inc.

Clinical trials sponsored by Truebinding, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug TB006 aims to ease movement problems in Parkinson's Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1 Terminated 1

Alzheimer's drug TB006 safety study halted early

Disease control Stopped early

This study looked at the long-term safety of an experimental drug called TB006 (oloctinebart) in people with Alzheimer's disease. It included 119 participants who had either completed a previous TB006 study or were new to the drug. The study was terminated early, so the full safe…

Phase 2 • Sponsor: TrueBinding, Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:29 UTC